Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380149304> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W4380149304 endingPage "S187" @default.
- W4380149304 startingPage "S187" @default.
- W4380149304 abstract "Pirtobrutinib is a reversible non-covalent BTKi agent that is currently being evaluated in patients with a variety of B-cell malignancies, including Mantle Cell Lymphoma (MCL) (NCT03740529, BRUIN, LOXO-BTK-18001). MCL is a rare condition diagnosed in less than 3,341 people per year in the United States (U.S.). This study was designed to estimate the annual population of patients with MCL who may be eligible for treatment with pirtobrutinib in commercial and Medicare health plans in the U.S." @default.
- W4380149304 created "2023-06-11" @default.
- W4380149304 creator A5036641783 @default.
- W4380149304 creator A5057940236 @default.
- W4380149304 creator A5073922485 @default.
- W4380149304 creator A5075218505 @default.
- W4380149304 creator A5077829446 @default.
- W4380149304 creator A5090793200 @default.
- W4380149304 date "2023-06-01" @default.
- W4380149304 modified "2023-09-26" @default.
- W4380149304 title "EPH131 Estimation of the Population of Patients Eligible for Pirtobrutinib after Covalent Bruton Tyrosine Kinase Inhibitor (CBTKI) Discontinuation in the United States" @default.
- W4380149304 doi "https://doi.org/10.1016/j.jval.2023.03.1013" @default.
- W4380149304 hasPublicationYear "2023" @default.
- W4380149304 type Work @default.
- W4380149304 citedByCount "0" @default.
- W4380149304 crossrefType "journal-article" @default.
- W4380149304 hasAuthorship W4380149304A5036641783 @default.
- W4380149304 hasAuthorship W4380149304A5057940236 @default.
- W4380149304 hasAuthorship W4380149304A5073922485 @default.
- W4380149304 hasAuthorship W4380149304A5075218505 @default.
- W4380149304 hasAuthorship W4380149304A5077829446 @default.
- W4380149304 hasAuthorship W4380149304A5090793200 @default.
- W4380149304 hasConcept C126322002 @default.
- W4380149304 hasConcept C170493617 @default.
- W4380149304 hasConcept C2777525834 @default.
- W4380149304 hasConcept C2778715236 @default.
- W4380149304 hasConcept C2779338263 @default.
- W4380149304 hasConcept C2908647359 @default.
- W4380149304 hasConcept C42362537 @default.
- W4380149304 hasConcept C71924100 @default.
- W4380149304 hasConcept C90059517 @default.
- W4380149304 hasConcept C99454951 @default.
- W4380149304 hasConceptScore W4380149304C126322002 @default.
- W4380149304 hasConceptScore W4380149304C170493617 @default.
- W4380149304 hasConceptScore W4380149304C2777525834 @default.
- W4380149304 hasConceptScore W4380149304C2778715236 @default.
- W4380149304 hasConceptScore W4380149304C2779338263 @default.
- W4380149304 hasConceptScore W4380149304C2908647359 @default.
- W4380149304 hasConceptScore W4380149304C42362537 @default.
- W4380149304 hasConceptScore W4380149304C71924100 @default.
- W4380149304 hasConceptScore W4380149304C90059517 @default.
- W4380149304 hasConceptScore W4380149304C99454951 @default.
- W4380149304 hasIssue "6" @default.
- W4380149304 hasLocation W43801493041 @default.
- W4380149304 hasOpenAccess W4380149304 @default.
- W4380149304 hasPrimaryLocation W43801493041 @default.
- W4380149304 hasRelatedWork W2419308557 @default.
- W4380149304 hasRelatedWork W2466043692 @default.
- W4380149304 hasRelatedWork W2595635579 @default.
- W4380149304 hasRelatedWork W2766844642 @default.
- W4380149304 hasRelatedWork W2883575734 @default.
- W4380149304 hasRelatedWork W2943412515 @default.
- W4380149304 hasRelatedWork W2964365162 @default.
- W4380149304 hasRelatedWork W3030489043 @default.
- W4380149304 hasRelatedWork W4323295439 @default.
- W4380149304 hasRelatedWork W4380149304 @default.
- W4380149304 hasVolume "26" @default.
- W4380149304 isParatext "false" @default.
- W4380149304 isRetracted "false" @default.
- W4380149304 workType "article" @default.